A common asthma medication used for decades is now drawing attention in cancer research after scientists found it may help the immune system fight some of the hardest cancers to treat. Researchers studying montelukast, a drug widely prescribed for asthma and allergies, say the medication showed encouraging results against aggressive tumors in early laboratory and animal studies.